Hospital Universitario Gaffree e Guinle

Rio de Janeiro, Rio de Janeiro 20270-004

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed